AsthmaTuner
Product and provider description
Target populations
Target condition & treatment
Adherence monitoring
Adherence support
Development and evaluation
Product and provider description
Brand name:
AsthmaTuner
AsthmaTuner
Full name:
AsthmaTuner
AsthmaTuner
Brief description:
This app for asthma treatment gives you an objective assessment of your asthma and which treatment is best for you. You use the lung function meter, which is recording your lung function in the app. The lung function value, FEV1, is then examined together with your self-reported symptoms and you receive an evaluation. You can share your asthma stats and information with your healthcare provider, making it easy for them to adjust your treatment. AsthmaTuner facilitates consultations with healthcare providers over the phone or video call.In the app you can follow your asthma over time, set reminders to take medication or test asthma status and follow family members.
This app for asthma treatment gives you an objective assessment of your asthma and which treatment is best for you. You use the lung function meter, which is recording your lung function in the app. The lung function value, FEV1, is then examined together with your self-reported symptoms and you receive an evaluation. You can share your asthma stats and information with your healthcare provider, making it easy for them to adjust your treatment. AsthmaTuner facilitates consultations with healthcare providers over the phone or video call.In the app you can follow your asthma over time, set reminders to take medication or test asthma status and follow family members.
Technology Readiness Level:
TRL 8: First commercial system
TRL 8: First commercial system
Date first available:
2018-03-09
2018-03-09
Date latest update:
2024-01-10
2024-01-10
Current version identifier:
iPhone: 5.4.13.3, Android: 5.4.13.8
iPhone: 5.4.13.3, Android: 5.4.13.8
Types of components:
Hardware, Software
Hardware, Software
Is the technology designed to be used as stand-alone or/and as component of a larger solution:
Both as stand-alone or component of a larger solution
Both as stand-alone or component of a larger solution
Languages:
Danish, English, Swedish
Danish, English, Swedish
Countries:
Sweden
Sweden
Do any terms and conditions apply?
No information available
No information available
Details terms and conditions:
https://api.asthmatuner.com/home/termsat/
https://api.asthmatuner.com/home/termsat/
Is the technology free of charge or a fee is required for its use?
Free
Free
Provider name:
MediTuner AB
MediTuner AB
Provider type:
Privately-owned or for-profit organisation, Public or state-owned organisation
Privately-owned or for-profit organisation, Public or state-owned organisation
Provider domain of activity:
Technology, Pharmaceutical, Healthcare
Technology, Pharmaceutical, Healthcare
Please contact the provider at:
info@medituner.se
info@medituner.se
Target populations
Is the MATech intended to be used for self-management?
Yes
Yes
Who interacts with the MATech for self-management?
Patient, Caregiver, Other
Patient, Caregiver, Other
Others interacting with the MATech for self-management
Relatives/ family
Relatives/ family
How many interact:
multiple persons/users (e.g. communication between different users possible via the MATech)
multiple persons/users (e.g. communication between different users possible via the MATech)
Patient age group(s) the MATech is suitable for:
Older adults – older than 65 years, Adults – 31 – 65 years old, Young adults – 18 – 30 years old, Adolescents – 12 – 17 years, Children – 1 – 11 years
Older adults – older than 65 years, Adults – 31 – 65 years old, Young adults – 18 – 30 years old, Adolescents – 12 – 17 years, Children – 1 – 11 years
Level of functioning in memory functions the MATech is suitable for:
not specified
not specified
Level of functioning in perception functions the MATech is suitable for:
not specified
not specified
Level of functioning in visual functions the MATech is suitable for:
not specified
not specified
Level of functioning in auditive functions the MATech is suitable for:
not specified
not specified
Level of functioning in movement & mobility the MATech is suitable for:
not specified
not specified
Is the MATech suitable for patients with low literacy (ability to read and write)?
No information available
No information available
Is the MATech suitable for patients with low health literacy (capacity to obtain, process and understand basic health information and services)?
No information available
No information available
Is the MATech suitable for patients with comorbidity?
No information available
No information available
Is the MATech suitable for patients with limited experience with technologies?
No information available
No information available
Is the MATech intended to be used for within an adherence support service?
Yes
Yes
Is the MATech intended to be used by health or social care providers?
No information available
No information available
Is the MATech intended to be used by administrators or health system managers?
No information available
No information available
Target condition & treatment
Target health condition domains for which the MATech is designed:
Respiratory
Respiratory
The MATech is suitable for medication prescribed:
Preventively (Medication are prescribed as prevention/prophylaxis against the occurrence of diseases or disease-related adverse events, e.g. exacerbations, organ rejections etc.), Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)
Preventively (Medication are prescribed as prevention/prophylaxis against the occurrence of diseases or disease-related adverse events, e.g. exacerbations, organ rejections etc.), Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)
The MATech is suitable for (treatment duration):
No information available
No information available
The MATech is suitable for (administration form):
Inhalation
Inhalation
The MATech is suitable for (single/polypharmacy):
Single drug treatments, Polypharmacy (combination therapies)
Single drug treatments, Polypharmacy (combination therapies)
The MATech is suitable for (dosage instructions):
Once-daily doses, Once-per-week doses, The technology is capable to deal with dose adjustments
Once-daily doses, Once-per-week doses, The technology is capable to deal with dose adjustments
The MATech is designed to be used for adherence monitoring or intervention:
Monitor/measure medication adherence, Intervene to support medication adherence
Monitor/measure medication adherence, Intervene to support medication adherence
The MATech is designed to be used in (adherence phases):
Initiation (when the person starts to take the medication prescribed), Implementation (during the period when the person takes the medication prescribed), Discontinuation (when the person stops taking the medication prescribed)
Initiation (when the person starts to take the medication prescribed), Implementation (during the period when the person takes the medication prescribed), Discontinuation (when the person stops taking the medication prescribed)
Adherence monitoring
Methods used by the MATech to measure adherence:
Self-report
Self-report
Behavioral aspects targeted by the MATech measurement component:
behaviour itself, outcomes
behaviour itself, outcomes
Behaviors targeted by the MATech measurement component:
No information available
No information available
Outcomes targeted by the MATech measurement component:
clinical (e.g. morbidity, mortality)
clinical (e.g. morbidity, mortality)
Adherence support
Modes of delivering adherence support used in the technology:
Electronic
Electronic
Printed material formats used:
No information available
No information available
Human interaction formats used:
Face-to-face consultations
Face-to-face consultations
Electronic formats used:
Use of a smartphone or tablet
Use of a smartphone or tablet
Smartphone/tablet formats used:
audio call, video call
audio call, video call
App features included:
includes diaries, includes a reminder system, uses gaming
includes diaries, includes a reminder system, uses gaming
Wearable device formats used:
No information available
No information available
Digital media formats used:
No information available
No information available
Behaviour change content of the intervention (e.g. what adherence barriers and facilitators are targeted, what behaviour change techniques it includes):
The app can give information about the treatment, set reminders, help planning the administration, demonstrate inhalation technique, setting goals, give feedback on behaviours, enable support from family and friends and facilitate healthcare communication.
The app can give information about the treatment, set reminders, help planning the administration, demonstrate inhalation technique, setting goals, give feedback on behaviours, enable support from family and friends and facilitate healthcare communication.
Types of intervention providers involved (i.e. persons using the technology to support patients manage adherence):
Medical doctor (Generalist medical practitioner, Specialist medical practitioner), Nursing professional, Pharmacist (Community pharmacist, Hospital pharmacist), Family member (Parent or guardian, Spouse or partner, child or grandchild, other), Friend
Medical doctor (Generalist medical practitioner, Specialist medical practitioner), Nursing professional, Pharmacist (Community pharmacist, Hospital pharmacist), Family member (Parent or guardian, Spouse or partner, child or grandchild, other), Friend
Types of intervention setting (i.e. where the technology is designed to be used for supporting adherence):
Household residence
Household residence
Telehealth environments applicable:
Telemedicine
Telemedicine
Development and evaluation
Brief description of how the technology has been developed and evaluated (e.g. transparency, theory and evidence base, context compatibility, co-creation, scientific evaluation, etc.):
The technology has been developed together with patients and healthcare professionals. The technology is based on GINA Guidelines. Studies have been performed to validate the technology. https://doi.org/10.1183/13993003.00983-2019 https://doi.org/10.1177/20552076221092542
The technology has been developed together with patients and healthcare professionals. The technology is based on GINA Guidelines. Studies have been performed to validate the technology. https://doi.org/10.1183/13993003.00983-2019 https://doi.org/10.1177/20552076221092542
Matech Disclaimer
ENABLE – COST Action CA19132 (ENABLE) maintains this website to enhance public access to our online repository where interested parties would be able to search for medication adherence technologies and learn about them for their research or practice.
Our goal is to keep this information timely and accurate. If errors are brought to our attention, we will try to correct them. However, ENABLE accepts no responsibility or liability whatsoever with regard to the information on this site.